**Drug Discovery and Proteins as Drug Targets**

**Introduction**

Proteins are the primary component of cells and tissues. Act as enzymes, catalyzing biochemical reactions, involved in metabolism, DNA replication, gene expression regulation, and cellular signaling transduction (1). Thus, proteins play an important role in conserving a complex network of cellular processes in a healthy state, as well as in disease states when their involvement becomes dysregulated.

For instance, a class of enzyme kinases that curb cellular growth and differentiation if they become hyperactive (upregulated), inducing malignant behavior in normal cells that leads to cancer cell formation (2). Given their crucial role in both health and disease, proteins have emerged as potential therapeutic targets for drug discovery and precision medicine.

**Why Proteins are Effective Drug Targets**

**Role in Cellular processes**

Since proteins conserve various cellular activities and involve signaling pathways to regulate growth, proliferation, and survival of cells, they are thus considered a potential drug target. Enzymes, membrane receptors, ion channels, and transporter proteins are the major drug target classes (3). In continuation with the above example, the Bcr-Abl tyrosine kinase constitutively activates cytokine signal transduction pathways in chronic myeloid leukemia (CML), promoting proliferation and inhibiting apoptosis of hematopoietic cells (4). Therefore, by targeting these dysregulated proteins drugs can disrupt pathogenic pathways and prevent disease progression.

**Specific 3D Structure**

Proteins have a unique 3D structure with specific active sites, which makes them excellent therapeutic targets. These active sites can be targeted by small molecules or biomolecules, enabling the discovery of potent drugs that bind to the protein of interest while minimizing off-target effects and avoiding toxicity (5). For example, small molecules targeting kinase enzyme active sites to block the proliferation of cancer cells

**Involvement in Multiple Biological Pathways**

Proteins have an essential role in a range of biological processes, which opens up various possible therapeutic approaches (1). By targeting a single protein that affects many downstream pathways, resulting in a more comprehensive impact on disease progression. This is especially important for complex multifactorial diseases such as cancer, where combination therapies targeting many pathways might combat resistance mechanisms and enhance treatment outcomes.

**Conclusion**

Proteins are prospective drug targets due to their involvement in a wide range of biological processes, specific structure, and paramount contribution to the progression of disease. The emergence of protein-targeted therapies has been revolutionizing the field of precision medicine for treating diseases including cancer and autoimmune disorders.

**References**

**1.Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2002). Analyzing protein structure and function. In Molecular Biology of the Cell. 4th edition. Garland Science. https\://www\.ncbi.nlm.nih.gov/books/NBK26820/#\_ncbi\_dlg\_citbx\_NBK26820**

**2.Cicenas, J., Zalyte, E., Bairoch, A., & Gaudet, P. (2018). Kinases and Cancer. Cancers, 10(3), 63. https\://doi.org/10.3390/cancers10030063**

**3.Bull, S. C., & Doig, A. J. (2015). Properties of protein drug target classes. PloS one, 10(3), e0117955. https\://doi.org/10.1371/journal.pone.0117955**

**4.Amarante-Mendes, G. P., Rana, A., Datoguia, T. S., Hamerschlak, N., & Brumatti, G. (2022). BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia. Pharmaceutics, 14(1), 215. https\://doi.org/10.3390/pharmaceutics14010215**

**5.Adelusi, T. I., Oyedele, A. Q. K., Boyenle, I. D., Ogunlana, A. T., Adeyemi, R. O., Ukachi, C. D., ... & Abdul-Hammed, M. (2022). Molecular modeling in drug discovery. Informatics in Medicine Unlocked, 29, 100880. https\://doi.org/10.1016/j.imu.2022.100880**

<!--[if !supportLists]-->1
